Naturally occurring IgM anti-leukocyte autoantibodies inhibit T-cell activation and chemotaxis

Journal of Clinical Immunology

Volumn 30, Issue SUPPL. 1, 2010, Pages

  Lobo, Peter I ^a,b   Schlegal, Kailo H ^a,b   Vengal, John ^a,b   Okusa, Mark D ^a,b   Pei, Hong ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Chemotaxis; IgM anti leukocyte; Naturally occurring autoantibodies; T cell activation

Indexed keywords

AUTOANTIBODY; CD3 ANTIGEN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; IMMUNOGLOBULIN M ANTILEUKOCYTE AUTOANTIBODY; PROTEIN KINASE ZAP 70; UNCLASSIFIED DRUG; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN RECEPTOR; LYMPHOKINE; ZAP70 PROTEIN, HUMAN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ISOLATION; CYTOKINE PRODUCTION; HEART TRANSPLANTATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; ISCHEMIA; LYMPHOCYTE PROLIFERATION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REPERFUSION INJURY; T LYMPHOCYTE ACTIVATION; ANIMAL; B LYMPHOCYTE; BIOSYNTHESIS; C57BL MOUSE; CELL DIVISION; CHRONIC KIDNEY FAILURE; CYTOLOGY; DRUG EFFECTS; FETUS BLOOD; IMMUNOLOGY; KIDNEY TRANSPLANTATION; LEUKOCYTE; LYMPHOCYTE ACTIVATION; METABOLISM; MIGRATION INHIBITION; MOUSE; NEWBORN; PHOSPHORYLATION; PROTEIN PROCESSING; T LYMPHOCYTE;

ANIMALS; AUTOANTIBODIES; B-LYMPHOCYTE SUBSETS; CELL DIVISION; CELL MIGRATION INHIBITION; FETAL BLOOD; HIV ANTIBODIES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT, NEWBORN; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LEUKOCYTES; LYMPHOCYTE ACTIVATION; LYMPHOKINES; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 77956198729     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-010-9412-7     Document Type: Article

References (20)

1. Hardy RR, Hayakawa K. Development and physiology of Ly-1 B and its human. homolog, Leu-1 B. Immunol Rev. 1986;93:53-79.
2. Ailus K, Palosuo T. IgM class autoantibodies in human cord blood. J Reprod Immunol. 1995;29:61-67
3. Lacroix-Desmazes S, Kaveri SV, Mouthon L, et al. Self-reactive antibodies (natural autoantibodies) in healthy individuals. J Immunol Methods. 1998;216:117-137
4. Fagarasan S, Honjo T. T-Independent immune response: new aspects of B cell biology. Science. 2000;290:89-92.
5. Brezinschek HP, Foster SJ, Brenzinschek RI, Dorner T, Domiati-Saad R, Lipsky PE. Analysis of human VH gene repertoire: differential effects of selection and somatic hypermutation on human peripheral CD5+/IgM and CD5-/IgM+ B cells. J Clin Invest. 1997;99:2488-2501
6. Terasaki PI, Mottironi VD, Barnett EV. Cytotoxins in disease. N Engl J Med. 1970;283:724-727
7. Winfield JB, Winchester RJ, Wernet P, Fu SM, Kunkle HG. Nature of cold-reactive antibodies to lymphocyte surface. Arthritis Rheum. 1975;18:1-8.
8. Lobo PI. Nature of autolymphocytotoxins present in renal hemodialysis patients: their possible role in controlling alloantibody formation. Transplantation. 1981;32:233-237
9. Lobo PI, Suratt PM. Studies on the autoantibody to lymphocytes in sarcoidosis. J Clin Lab Immunol. 1979;1:283-288
10. Dorsett B, Cronin W, Chuma V. Iochim Hl: Anti-lymphocyte antibodies in patients with the acquired immune deficiency syndrome. Am J Med. 1985;78:621-626
11. Griggi T, Bauer R, Garofalo T, et al. Autoantibodies against ganglioside GM3 represents a portion of antilymphocytic antibodies in AIDS patients. Scand J Immunol. 1994;40:77-82.
12. Sorice M, Lenti L, Misasi R, et al. Anti-glycosphingolipid antibodies in HIV infection. AIDS. 1991;5:345-346
13. Stimmler MM, Quismorio FPJ, McGehee WG, Boylen T, Sharma OP. Anticardiolipin antibodies in acquired immunodeficiency syndrome [see comments]. Arch Intern Med. 1989;149:1833-1835
14. Lobo PI, Rudolf L, Westervelt FB. Enhanced kidney allograft survival across a positive crossmatch (Cx) arising from B-cell specific and cold reactive antibodies. Proc Dial Transp Forum. 1977;7:4-6.
15. Iwaki Y, Terasaki PI, Park MS, Billing R. Enhancement of human kidney allografts by cold B-lymphocyte cytotoxins. Lancet. 1978;1:1228-1229
16. Kerman RH, Susskind B, Buyse I, et al. Flow cytometry-detected IgG is not a contraindication to renal transplantation: IgM may be beneficial to outcome. Transplantation. 1999;68:1855-1858
17. Lobo PI, Schlegel KH, Spencer CE, et al. Naturally occurring IgM anti-leukocyte autoantibodies (IgM-ALA) inhibit T cell activation and chemotaxis. J Immunol. 2008;180:1780-1791
18. Jiang H, Chess L. Regulation of immune responses by T cells. N Eng J Med. 2006;354:1166-1176
19. Sakaguchi S, Sakaguchi N, Shimizu J, et al. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev. 2001;182:18-32.
20. Ludewig B, Krebs P, Junt T, Bocharov G. Dendritic cell homeostasis in the regulation of self-reactivity. Curr Pharm Des. 2003;9:221-231